Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 559, pseudogene (RNU6-559P) is a human pseudogene annotated at locus 9p22.3, corresponding to an inactive variant of a U6 small nuclear RNA gene. U6 snRNA genes encode RNAs essential for pre-mRNA splicing, but as a pseudogene, RNU6-559P does not express functional RNA and does not have known biological or disease associations. There are no reported interacting drugs, mechanisms of action, or recognized roles as a therapeutic target. It is listed in the HGNC database with symbol RNU6-559P and accession HGNC:47522. It appears in gene annotation resources such as Ensembl (ENSG00000251960, species Homo sapiens). As a pseudogene, RNU6-559P is a molecular remnant, not encoding a functional product or participating in known physiologic or pathological processes. No aliases beyond the standard symbol are commonly recognized. There are no reports of disease implication, biomarker utility, or safety concerns. Pseudogenes are generally not considered valid therapeutic or drug targets, as they do not produce functional molecules in normal or disease biology, and this is also the case for RNU6-559P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 559, pseudogene (RNU6-559P).